The global EPA & DHA omega-3 market is experiencing significant growth, driven by rising health awareness, increasing demand for nutritional supplements, and expanding applications in pharmaceuticals, infant nutrition, and functional foods. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential long-chain omega-3 fatty acids associated with cardiovascular health, brain function, vision, and healthy development. As consumers increasingly prioritize preventive healthcare and nutritional wellness, manufacturers are expanding their product portfolios to meet demand for high-quality omega-3 ingredients. The market includes several sources, such as fish oil, krill oil, cod liver oil, and algal oil, each offering distinct nutritional, formulation, and sustainability benefits.

According to The Insight Partners, The EPA & DHA omega-3 Market size is expected to reach US$ 204.62 Billion by 2034 from US$ 88. Billion in 2025. The market is estimated to record a CAGR of 9.83% from 2026 to 2034.. The market outlook reflects growing interest in omega-3 supplementation, advancements in ingredient processing, and increasing demand across health and nutrition industries. Dietary supplements remain an important application area, while pharmaceutical products and infant formula offer additional opportunities for specialized EPA and DHA formulations.

Get Sample Report https://www.theinsightpartners.com/sample/TIPRE00014931

 Market Report Drivers

Increasing Awareness of Cardiovascular Health Benefits

Growing awareness of cardiovascular health is a major driver of the EPA & DHA omega-3 market. Consumers are increasingly interested in nutritional products that support heart health and help maintain healthy triglyceride levels as part of an appropriate diet and healthcare plan. EPA and DHA are widely incorporated into fish oil supplements, softgels, capsules, and concentrated omega-3 formulations. Healthcare professionals' recommendations and the availability of products through pharmacies, specialty nutrition stores, and online platforms further support market development. Manufacturers are responding by offering products with different concentrations, dosage forms, and combinations to serve diverse consumer needs.

Rising Demand for Brain and Cognitive Health Nutrition

The growing focus on brain health, cognitive performance, and healthy aging is creating additional demand for DHA-rich products. DHA is an important structural component of the brain and retina, making it particularly relevant to prenatal nutrition, infant development, and vision-related nutritional formulations. EPA is also used in products targeting broader wellness needs. As consumers become more aware of the role of essential fatty acids throughout different life stages, supplement manufacturers are developing targeted formulations for adults, older consumers, and families. This expanding consumer base supports demand across both established and emerging nutrition markets.

Expanding Applications in Pharmaceuticals and Infant Formula

The use of EPA and DHA in pharmaceutical products and infant formula is another important market driver. Pharmaceutical applications require ingredients that meet stringent purity, quality, and consistency requirements. Meanwhile, infant nutrition manufacturers incorporate DHA and, in many formulations, EPA to support nutritional composition and product differentiation. Increasing investment in specialized ingredients, quality assurance, and formulation technologies is helping suppliers address these requirements. Growth in these applications creates opportunities for companies capable of delivering traceable, stable, and application-specific omega-3 ingredients.

Key Trends in the EPA & DHA Omega-3 Market

Shift Toward Sustainable and Plant-Based Omega-3 Sources

Sustainability is becoming a defining trend in the global EPA & DHA omega-3 market. Traditional marine sources remain important, but concerns about fishing pressure, marine ecosystem conservation, and raw material availability are encouraging manufacturers to diversify sourcing strategies. Algal oil is gaining attention because it provides a non-fish source of omega-3 fatty acids and can be suitable for vegetarian and vegan formulations, depending on the finished product. Advances in algae cultivation and extraction are helping suppliers develop ingredients for dietary supplements, fortified foods, and infant nutrition. Sustainable sourcing, traceability, and responsible production practices are increasingly important for manufacturers seeking to strengthen consumer trust.

Product Innovation and Advanced Formulations

Manufacturers are investing in technologies that improve omega-3 concentration, oxidation stability, taste, and formulation performance. Fishy aftertaste and odor can affect consumer acceptance, encouraging the development of deodorized oils, improved encapsulation methods, and enhanced delivery systems. Concentrated EPA and DHA ingredients also allow manufacturers to formulate products with specific fatty acid profiles. Innovations in softgels, emulsions, powders, and fortified food applications are expanding the ways omega-3 ingredients can be incorporated into daily nutrition. These developments create opportunities for premium products that combine convenience, quality, and targeted nutritional benefits.

Personalized Nutrition and Preventive Healthcare

Personalized nutrition is influencing the development of omega-3 products designed for specific age groups, dietary preferences, and wellness goals. Consumers are increasingly seeking supplements that align with their individual nutritional needs, including products for heart health, cognitive wellness, pregnancy nutrition, and healthy aging. Digital health platforms and direct-to-consumer sales channels are also making specialized supplements more accessible. This trend encourages manufacturers to diversify their product portfolios, improve consumer education, and develop differentiated formulations for specific market segments.

Opportunities in the Global EPA & DHA Omega-3 Market

Growth in Plant-Based and Alternative Ingredients

Algal oil offers a promising opportunity for companies seeking alternatives to conventional marine-derived omega-3 ingredients. Its suitability for plant-based product positioning can help suppliers reach vegan consumers and individuals who prefer non-fish sources. Investment in algae cultivation, fermentation, extraction, and production efficiency could improve supply flexibility and support broader commercialization. Companies that develop scalable production processes and reliable ingredient quality may strengthen their position in the expanding alternative omega-3 segment.

Expansion Across Emerging Markets

Growing interest in preventive healthcare, rising disposable incomes, and increasing availability of nutritional supplements are creating opportunities in developing economies. Improved access to pharmacies, e-commerce platforms, and modern retail channels is helping omega-3 products reach more consumers. Manufacturers can address these markets through affordable formulations, localized product portfolios, and educational campaigns explaining the nutritional role of EPA and DHA. Partnerships with regional distributors and healthcare professionals can further support market penetration.

Functional Foods and Specialized Nutrition

The integration of omega-3 ingredients into functional foods and beverages provides another avenue for market expansion. Food manufacturers can incorporate EPA and DHA into selected fortified products, nutrition powders, and specialized dietary formulations. However, success depends on maintaining ingredient stability, managing flavor, and ensuring compatibility with processing conditions. Ingredient suppliers that provide technical support and application-specific solutions can build stronger relationships with food and beverage manufacturers.

Market Segmentation Analysis

The global EPA & DHA omega-3 market is segmented by type and application, reflecting the variety of ingredient sources and end-use requirements.

 By Type: Fish oil, krill oil, cod liver oil, and algal oil. Fish oil remains an established source, while algal oil provides an alternative for plant-based formulations.

By Application: Dietary supplements, pharmaceutical products, infant formulae, and other applications. Demand is supported by consumer nutrition, specialized healthcare products, and the growing use of omega-3 ingredients in formulated nutrition.

Regional demand varies with consumer awareness, supplement penetration, healthcare infrastructure, regulatory requirements, and access to raw materials. North America and Europe benefit from established supplement markets, while Asia-Pacific offers opportunities associated with expanding consumer health awareness and demand for specialized nutrition products.

Top Players in the EPA & DHA Omega-3 Market

The competitive landscape includes ingredient manufacturers, specialty nutrition companies, and suppliers of marine-derived and algal omega-3 ingredients. Key companies identified in The Insight Partners' market coverage include:

• Cargill, Inc.
• BASF SE
• Wiley Organics, Inc.
• NORDIC NATURALS
• Croda, Inc.
• DSM
• Clover Corporation
• Omega Protein
• Epax Norway AS (Pelagia AS)
• Lonza Ltd.

Market participants are focusing on product innovation, ingredient quality, sustainable sourcing, strategic partnerships, and expansion into specialized nutrition applications. Differentiated formulations and reliable supply chains are likely to remain important competitive factors.

Future Outlook

The future of the global EPA & DHA omega-3 market will be shaped by the convergence of preventive healthcare, specialized nutrition, and sustainable ingredient production. Growing consumer interest in cardiovascular wellness, cognitive health, and healthy aging is expected to support continued demand for omega-3 supplements and fortified nutritional products.

Algal oil and other alternative production technologies may help diversify supply and address sustainability concerns. Meanwhile, advances in purification, encapsulation, and oxidation control are likely to improve product quality and expand formulation possibilities. Pharmaceutical applications and infant nutrition will continue to require reliable ingredient specifications and rigorous quality management.

Companies that combine scientific research, transparent sourcing, efficient production, and consumer-focused innovation will be well positioned to capture emerging opportunities. Market participants will also need to navigate regulatory requirements, raw material price fluctuations, and competition from alternative ingredients. Overall, innovation and wider access to specialized nutrition products are expected to remain central to the industry's long-term development.

Related Report

Omega-3 Ingredients Market by Expert Industy Analysis 2031

Omega-3 PUFA Market Growth, Demand & Size by 2034